An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
作者信息
Hartwell Matthew J, Özbek Umut, Holler Ernst, Renteria Anne S, Major-Monfried Hannah, Reddy Pavan, Aziz Mina, Hogan William J, Ayuk Francis, Efebera Yvonne A, Hexner Elizabeth O, Bunworasate Udomsak, Qayed Muna, Ordemann Rainer, Wölfl Matthias, Mielke Stephan, Pawarode Attaphol, Chen Yi-Bin, Devine Steven, Harris Andrew C, Jagasia Madan, Kitko Carrie L, Litzow Mark R, Kröger Nicolaus, Locatelli Franco, Morales George, Nakamura Ryotaro, Reshef Ran, Rösler Wolf, Weber Daniela, Wudhikarn Kitsada, Yanik Gregory A, Levine John E, Ferrara James Lm
出版信息
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.124015.
Abstract
摘要
相似文献
1
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.一种早期生物标志物算法可预测致死性移植物抗宿主病及生存率。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.124015.
2
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.一种早期生物标志物算法可预测致命的移植物抗宿主病和存活率。
JCI Insight. 2017 Feb 9;2(3):e89798. doi: 10.1172/jci.insight.89798.
3
Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.移植前血清白蛋白下降可预测黏膜炎性清髓性预处理后随后发生的严重急性移植物抗宿主病。
Biol Blood Marrow Transplant. 2016 Jun;22(6):1137-1141. doi: 10.1016/j.bbmt.2016.03.010. Epub 2016 Mar 14.
4
Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.全身淋巴照射后对同种异体移植排斥反应和移植物抗宿主病的同时保护作用：自然杀伤T细胞的作用
Transplantation. 2008 Feb 27;85(4):607-14. doi: 10.1097/TP.0b013e31816361ce.
5
Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.供体淋巴细胞输注后的移植物抗白血病反应和移植物抗宿主反应由宿主型抗原呈递细胞启动，并在早期和长期嵌合体中由调节性T细胞调节。
Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519.
6
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.在成人中，以骨髓作为干细胞来源可改善无移植物抗宿主病、无复发的生存率。
Haematologica. 2016 Jun;101(6):764-72. doi: 10.3324/haematol.2015.138990. Epub 2016 Apr 1.
7
Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease.糖皮质激素治疗开始后的早期高血糖可预测急性移植物抗宿主病患者的不良预后。
Biol Blood Marrow Transplant. 2017 Jul;23(7):1186-1192. doi: 10.1016/j.bbmt.2017.03.010. Epub 2017 Mar 8.
8
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.药效动力学监测预测 CCR5 阻断作为移植物抗宿主病预防的疗效。
Biol Blood Marrow Transplant. 2018 Mar;24(3):594-599. doi: 10.1016/j.bbmt.2017.10.028. Epub 2017 Oct 20.
9
Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.使用淋巴因子激活的杀伤细胞预防骨髓移植排斥和致死性移植物抗宿主病。
J Immunol. 1989 Sep 1;143(5):1524-9.
10
Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.通过短期给予LF 08 - 0299预防小鼠异基因骨髓移植后致死性移植物抗宿主病。
Transplantation. 1996 Sep 27;62(6):721-9. doi: 10.1097/00007890-199609270-00004.
引用本文的文献
1
Identification and validation of tissue-based gene biomarkers for acute intestinal graft-versus-host disease(AIGVHD).急性肠道移植物抗宿主病（AIGVHD）基于组织的基因生物标志物的鉴定与验证。
Front Immunol. 2025 May 13;16:1574904. doi: 10.3389/fimmu.2025.1574904. eCollection 2025.
2
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients.黑人和白人患者之间急性移植物抗宿主病（GVHD）严重程度及其结局的差异。
Transplant Cell Ther. 2024 Nov;30(11):1061.e1-1061.e10. doi: 10.1016/j.jtct.2024.08.019. Epub 2024 Sep 1.
3
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD.新型 MAGIC 综合评分结合临床症状和生物标志物，可更好地预测急性移植物抗宿主病的治疗效果。
Blood. 2024 Aug 29;144(9):1010-1021. doi: 10.1182/blood.2024025106.
4
ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?ST2和Reg3α：它们能否预测小儿造血干细胞移植后急性移植物抗宿主病、类固醇难治性以及移植相关死亡率？
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S129-S135. doi: 10.1016/j.htct.2024.02.026. Epub 2024 Apr 17.
5
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.急性移植物抗宿主病的发作：西奈山急性移植物抗宿主病国际联盟分析
Blood Adv. 2024 Apr 23;8(8):2047-2057. doi: 10.1182/bloodadvances.2023012091.
6
Planning GvHD preemptive therapy: risk factors, biomarkers, and prognostic scores.规划移植物抗宿主病抢先治疗：风险因素、生物标志物和预后评分。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):149-154. doi: 10.1182/hematology.2023000425.
7
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.初发迟发性急性移植物抗宿主病的发生率、临床表现、危险因素、结局和生物标志物。
Blood Adv. 2023 Aug 22;7(16):4479-4491. doi: 10.1182/bloodadvances.2023009885.
8
The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.可溶性 VCAM-1 水平是预测异基因造血细胞移植后严重急性移植物抗宿主病的潜在生物标志物。
BMC Cancer. 2022 Sep 20;22(1):997. doi: 10.1186/s12885-022-10096-3.
9
Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.异基因造血细胞移植后维生素 D 缺乏可促进 T 细胞活化，并与 EZH2-ID3 特征呈负相关。
Transplant Cell Ther. 2022 Jan;28(1):18.e1-18.e10. doi: 10.1016/j.jtct.2021.09.017. Epub 2021 Sep 28.
10
Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?骨髓移植耐受：间充质基质细胞在急性或慢性移植物抗宿主病中仍有未来吗？
Front Immunol. 2020 Dec 11;11:609063. doi: 10.3389/fimmu.2020.609063. eCollection 2020.
Zotero 插件